LONDON (Reuters) - GlaxoSmithKline Plc is acquiring Biotene, a leading over-the-counter treatment for dry mouth, for $170 million in a move to bolster its consumer healthcare business. The world's ...
Sometimes an OTC brand looks like a DTC brand—and sometimes an OTC brand helps patients using DTC brands. This is the case with GSK’s Biotene. Although Biotene is not an Rx product, it is for people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback